Molecular design of new antibiotics and antibiotic adjuvants against MCR strains
US-12473250-B2 · Nov 18, 2025 · US
by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C217/20 |
| Official title | by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms |
| Display label | by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms |
| Total patents | 57 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 6 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Donor-acceptor conjugated oligoelectrolytes for cell labelling and methods thereof
US-2025347685-A1 · Nov 13, 2025 · US
Methods and materials for increasing level of phosphorylated AMPK protein
US-12428378-B2 · Sep 30, 2025 · US
Method for inhibiting or disrupting biofilm formation, or reducing biofilm
US-12398092-B2 · Aug 26, 2025 · US
Antibacterial composition
US-2025120944-A1 · Apr 17, 2025 · US
FOXM1 inhibitor compositions and methods of using the same
US-12187662-B2 · Jan 7, 2025 · US
Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
US-2024308951-A1 · Sep 19, 2024 · US
Alkoxy compounds for disease treatment
US-12029708-B2 · Jul 9, 2024 · US
Method for inhibiting or disrupting biofilm formation, or reducing biofilm
US-2023365491-A1 · Nov 16, 2023 · US
Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
US-11795136-B2 · Oct 24, 2023 · US
Short conjugated oligoelectrolytes and uses thereof
US-11713318-B2 · Aug 1, 2023 · US
Organic ligands for templatable mesoscale nanocapsules
US-11708530-B2 · Jul 25, 2023 · US
Alkoxy compounds for disease treatment
US-2023218549-A1 · Jul 13, 2023 · US
Alkoxy compounds for disease treatment
US-11446261-B2 · Sep 20, 2022 · US
Molecular design of new antibiotics and antibiotic adjuvants against mcr strains
US-2022281803-A1 · Sep 8, 2022 · US
Cationic pillararene compounds and compositions
US-2022119339-A1 · Apr 21, 2022 · US
Cationic pillararenes and uses thereof
US-11161801-B2 · Nov 2, 2021 · US
Salts of Zuclomiphene
US-2021292272-A1 · Sep 23, 2021 · US
Organic Ligands For Templatable Mesoscale Nanocapsules
US-2021179939-A1 · Jun 17, 2021 · US
Methods for the Treatment of Diabetic Retinopathy and other Ophthalmic Diseases
US-2021171435-A1 · Jun 10, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C217/20?
- CPC C07C217/20 is the Cooperative Patent Classification code for “by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms.”
- How many patents are filed under CPC C07C217/20 (by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms)?
- Our database includes 57 publications tagged with this CPC code.
- Is patent activity under CPC C07C217/20 growing?
- Publication counts under this code: 2 in 2024 vs 6 in 2025 (latest complete years).